Device Trial Radar · NCT05864248
Feasibility Study SA of the Supira System for HRPCI
Last checked: Nov 20, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
71
Actual
Start
Sep 13, 2023
Primary completion
Feb 6, 2026
Study completion Feb 6, 2026
Sponsor
- Lead sponsor
- Supira MedicalNot on our public-company list
- Sponsor type
- Industry
- First posted
- May 18, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Device feasibility
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective is to assess the feasibility and safety of the Supira System in providing temporary cardiovascular hemodynamic support in patients undergoing high-risk percutaneous interventions (HRPCI).
Conditions
- Heart Diseases
- Coronary Artery Disease (CAD)
- Heart Failure
Interventions
Supira SystemDevice
The Supira System is a temporary (≤ 4 hours) ventricular support device indicated for use during elective or urgent high-risk percutaneous coronary interventions (HRPCI) performed in hemodynamically stable patients with severe coronary artery disease when a heart team has determined HRPCI is the appropriate therapeutic option.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary Feasibility Endpoint: Successful initiation and maintenance of hemodynamic support without sustained hypotension throughout the index procedure.Time frame: From device delivery through device removal (up to 4 hours).
- Primary Safety Endpoint: Rate of composite major device-related adverse events (MDRAEs), from device delivery through device removal.Time frame: From device delivery through device removal (up to 4 hours).
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Instituto Dante Pazzanese De Cardiologia (Dante)
São Paulo, Brazil
'Instituto Do Coração de São Paulo (InCor)'
São Paulo, Brazil
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.